<DOC>
	<DOCNO>NCT00261950</DOCNO>
	<brief_summary>The purpose study evaluate effect cinacalcet marker bone turnover patient kidney disease receive dialysis .</brief_summary>
	<brief_title>Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism End Stage Renal Disease</brief_title>
	<detailed_description>Secondary hyperparathyroidism ( HPT ) common people end stage renal disease ( kidney disease ) . Patients secondary HPT often enlarge parathyroid gland neck result often elevate parathyroid hormone ( PTH ) level . Patients secondary HPT may bone disease ( osteodystrophy ) . Cinacalcet use decrease PTH level patient secondary HPT . Patients secondary HPT may bone disease ( osteodystrophy ) . This bone disease may cause bone pain , fracture , poor formation red blood cell . The purpose study evaluate effect cinacalcet marker bone turnover patient kidney disease receive dialysis .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Subjects eligible study meet follow criterion : One Intact Parathyroid Hormone ( iPTH ) determination obtain central laboratory must &gt; /= 300 pg/mL . One serum calcium determination obtain central laboratory must &gt; /= 8.4 mg/dL ( 2.1 mmol/L ) . One Bone Alkaline Phosphatase ( BALP ) determination obtain central laboratory must &gt; /= 20.9 ng/mL . Positive histologic confirmation high bone turnover disease assess central bone histology center . Treated dialysis &gt; /= 1 month date inform consent . Subjects ineligible study : Have unstable medical condition judgment investigator . Are pregnant nursing woman . Had parathyroidectomy 3 month date inform consent . For subject prescribe vitamin D , receive vitamin D therapy le 30 day day 1 require change vitamin D brand dose level within 30 day day 1 . Ever receive therapy Sensipar®/Mimpara®</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Cinacalcet HCl , Cinacalcet , Amgen ( AMG ) 073 , Sensipar , Mimpara , Calcimimetic</keyword>
</DOC>